Literature DB >> 24239056

Factors associated with perceived stigma of epilepsy in Croatia: a study using the revised Epilepsy Stigma Scale.

Ivan Bielen1, Latica Friedrich2, Ana Sruk2, Miljenka Planjar Prvan2, Sanja Hajnšek3, Zeljka Petelin3, Renata Sušak4, Marija Candrlić4, Ann Jacoby5.   

Abstract

PURPOSE: It is believed that a large number of factors influence feelings of stigma, but their relative contribution is not yet entirely clear. Most studies to date were conducted using the Epilepsy Stigma Scale (ESS); only one used a revised version of the ESS (rESS). The following study aims to determine factors contributing to epilepsy stigma in outpatients with chronic epilepsy in Croatia, and to analyze some psychometric properties of the Croatian translation of the rESS.
METHODS: Alongside standard testing for validity of the scale, a simulation model of the original ESS (smESS) was created. This model, which does not include a grading Likert 0-3 scale, was compared with the rESS.
RESULTS: In total, 159 out of 298 subjects (53%) reported feeling stigmatised, with 136 (45%) mild to moderately and 23 (8%) highly. Internal consistency of the Croatian translation of the rESS was 0.887. Feelings of stigma were significantly associated with age ≤ 50 years, younger age of epilepsy onset, more than 50 seizures to date, generalized tonic-clonic seizures, and a shorter seizure-free period. Multiple stepwise regression showed number of seizures to date as a significant variable (Beta=0.246). By adapting data into the smESS significant associations with younger age and age of epilepsy onset were lost. Internal consistency of the smESS was 0.849.
CONCLUSIONS: The Croatian translation of the rESS has been proved to be a suitable instrument for diagnosing epilepsy stigma. The results of our model point to the possibility that the rESS might be more sensitive than the original ESS.
Copyright © 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Croatia; Epilepsy; Internal consistency; Stigma; Stigma scale

Mesh:

Year:  2013        PMID: 24239056     DOI: 10.1016/j.seizure.2013.10.008

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  7 in total

1.  Reexamining epilepsy-associated stigma: validation of the Stigma Scale of Epilepsy in Zambia.

Authors:  Melissa A Elafros; Ryan P Bowles; Masharip Atadzhanov; Edward Mbewe; Alan Haworth; Elwyn Chomba; Gretchen L Birbeck
Journal:  Qual Life Res       Date:  2014-11-22       Impact factor: 4.147

2.  Whether the Presence of Depressions Increases Stigmatization of People with Epilepsy?

Authors:  Enra Suljic; Aida Hrelja; Tarik Mehmedika
Journal:  Mater Sociomed       Date:  2018-12

3.  Felt Stigma and Its Underlying Contributors in Epilepsy Patients.

Authors:  Lingyan Mao; Keying Wang; Qianqian Zhang; Jing Wang; Yanan Zhao; Weifeng Peng; Jing Ding
Journal:  Front Public Health       Date:  2022-04-26

Review 4.  Stigmatizing Diagnoses in Neurosurgery: A Narrative Review.

Authors:  Cara L Sedney; Patricia Dekeseredy; Treah Haggerty
Journal:  World Neurosurg       Date:  2020-09-02       Impact factor: 2.104

5.  The Perceived Stigma in Patients with Alopecia and Mental Disorder: A Comparative Study.

Authors:  Seval Dogruk Kacar; Ethem Soyucok; Erman Bagcioglu; Pınar Ozuguz; Kerem Senol Coskun; Ahmet Hakki Asık; Hasan Mayda
Journal:  Int J Trichology       Date:  2016 Jul-Sep

6.  Stigma and Polytherapy: Predictors of Quality of Life in Patients with Epilepsy from South India.

Authors:  M Nagarathnam; B Vengamma; B Shalini; Saa Latheef
Journal:  Ann Indian Acad Neurol       Date:  2017 Jul-Sep       Impact factor: 1.383

7.  Prevalence and associated factors of perceived stigma among medically ill patients on follow-up screened positive for depression in Ethiopia: facility-based cross-sectional study.

Authors:  Wondale Getinet Alemu; Sewbesew Yitayih Tilahun; Endale Bekele; Behailu Eshitu; Habtamu Kerebih
Journal:  BMJ Open       Date:  2022-01-31       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.